Henry Schein, Inc.
HSIC Healthcare Medical Distribution
Henry Schein, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $13.2 billion, up 4.03% from fiscal 2024. In the quarter to June 2026, revenue grew 6.73%, EPS grew 16.9%, free cash flow grew 140.9% and total debt rose 15.2%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.
Follow HSIC
Henry Schein, Inc. (HSIC) Book value per share
Henry Schein, Inc.'s book value per share at the end of fiscal 2025 was 32.3×, unchanged from fiscal 2024. At the end of the quarter to 30 June 2026 it was 33.6×. Over the past ten years it has ranged from 17.3× (fiscal 2016) to 32.8× (fiscal 2023); the current reading is higher than 91% of that period. Henry Schein, Inc. ranks 1st of 11 Medical Distribution companies by book value per share.
Book value per share, annual
Embed this chart
Annual newest first
| Period | Book value per share | Change |
|---|---|---|
| FY2025 | 32.3× | 1.51% |
| FY2024 | 31.8× | (3.18%) |
| FY2023 | 32.8× | 9.10% |
| FY2022 | 30.1× | 3.77% |
| FY2021 | 29.0× | 3.73% |
| FY2020 | 28.0× | 13.85% |
| FY2019 | 24.6× | 5.85% |
| FY2018 | 23.2× | 28.79% |
| FY2017 | 18.0× | 3.96% |
| FY2016 | 17.3× | (0.55%) |
Quarterly newest first
| Period | Book value per share | Change |
|---|---|---|
| Jun 2026 | 33.6× | (1.32%) |
| Mar 2026 | 34.1× | 5.65% |
| Dec 2025 | 32.3× | (3.57%) |
| Sep 2025 | 33.5× | (0.18%) |
| 42 more quarters | Free account |
Against its own ten years
Book value per share against peers
| Company | Book value per share |
|---|---|
| HSIC Henry Schein, Inc. | 33.6× |
| COR Cencora, Inc. compare | 16.8× |
| COSM Cosmos Health Inc. compare | 0.3× |
| AHG Akso Health Group Sponsored ADR compare | 0.0× |
| HKPD Cellyan Biotechnology Co., Ltd compare | 0.0× |
| FOCL FocalTherics compare | −0.1× |
| ACH Accendra Health, Inc. compare | −7.2× |
| CAH Cardinal Health, Inc. compare | −11.5× |
| MCK McKesson Corporation compare | −32.6× |
What Book value per share is
BV per Share tells an investor how much of a company’s accounting net worth stands behind each share.
(Shareholders Equity (Total) ÷ Shares (Basic, Weighted))
More on HSIC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement